Cargando…
Immune regulation and cytotoxic T cell activation of IL-10 agonists – Preclinical and clinical experience
The expansion and activation of tumor antigen reactive CD8(+) T cells are primary goals of immunotherapies for cancer. IL-10 is an anti-inflammatory cytokine with an essential role in the development and proliferation of regulatory T cells, restricting myeloid and chronic inflammatory T cell respons...
Autor principal: | Oft, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129358/ https://www.ncbi.nlm.nih.gov/pubmed/31706853 http://dx.doi.org/10.1016/j.smim.2019.101325 |
Ejemplares similares
-
Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8(+) T cells
por: Emmerich, Jan, et al.
Publicado: (2012) -
PEGylated IL-10 Activates Kupffer Cells to Control Hypercholesterolemia
por: Chan, Ivan H., et al.
Publicado: (2016) -
Balancing the immune response in the brain: IL-10 and its regulation
por: Lobo-Silva, Diogo, et al.
Publicado: (2016) -
Regulatory T Cells and IL-10 Independently Counterregulate Cytotoxic T Lymphocyte Responses Induced by Transcutaneous Immunization
por: Stein, Pamela, et al.
Publicado: (2011) -
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells
por: Ma, Xiaojing, et al.
Publicado: (2015)